Michael Vincent Meluzio
VP, Prin. Accounting Officer at Cue Biopharma · 6 reported transactions in 1 company · latest trade Oct 12, 2026
Their trades
Sold | Oct 12, 2026 | Oct 12, 2026 close $24.61 → Oct 29, 2026 close $21.45. S&P 500 −0.7% over the same days. | ||
Sold | Aug 13, 2026 | Aug 13, 2026 close $31.08 → Oct 29, 2026 close $21.45. S&P 500 −0.7% over the same days. | ||
Sold | Aug 13, 2026 | Aug 13, 2026 close $31.08 → Oct 29, 2026 close $21.45. S&P 500 −0.7% over the same days. | ||
Sold | Aug 13, 2026 | Aug 13, 2026 close $31.08 → Oct 29, 2026 close $21.45. S&P 500 −0.7% over the same days. |
SoldCue Biopharma
$32.1K
Oct 12, 2026 close $24.61 → Oct 29, 2026 close $21.45. S&P 500 −0.7% over the same days.
SoldCue Biopharma
$93.39
Aug 13, 2026 close $31.08 → Oct 29, 2026 close $21.45. S&P 500 −0.7% over the same days.
SoldCue Biopharma
$124.6K
Aug 13, 2026 close $31.08 → Oct 29, 2026 close $21.45. S&P 500 −0.7% over the same days.
SoldCue Biopharma
$44.6K
Aug 13, 2026 close $31.08 → Oct 29, 2026 close $21.45. S&P 500 −0.7% over the same days.